Concepedia

Hirva Mamdani

HM

Statistics

Publications

41

Citations

1.2K

H-Index

21

Active since

2015

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Wayne State University

Indiana University – Purdue University Indianapolis

Sarah Cannon

Memorial Sloan Kettering Cancer Center

Hirva Mamdani is an author at The Barbara Ann Karmanos Cancer Institute specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2015–2025

41

Publications

41

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

Navneet Singh, Sarah Temin, Sherman Baker et al. · Journal of Clinical Oncology · 2022 · 124 citations

, , +17

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

Navneet Singh, Sarah Temin, Sherman Baker et al. · Journal of Clinical Oncology · 2022 · 113 citations

, , +14

Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies

Melissa L. Johnson, Anthony B. El-Khoueiry, Navid Hafez et al. · Clinical Cancer Research · 2021 · 62 citations · Full text

, , +17

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)

Robin Cornelissen, Arsela Prelaj, Sophie Sun et al. · Journal of Thoracic Oncology · 2023 · 55 citations · Full text

, , +12

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.1

Navneet Singh, Ishmael Jaiyesimi, Nofisat Ismaila et al. · Journal of Clinical Oncology · 2023 · 50 citations

, , +13

1–5 of 41